Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TNGX compared with RVMD: revenue, margins and what each company keeps, and the suppliers and customers both name
TNGX
Tango Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
RVMD
Revolution Medicines, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TNGX
Tango Therapeutics, Inc.
vs
RVMD
Revolution Medicines, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
TNGX
Tango Therapeutics, Inc.
Change
23.24
▲
+6.79%
· post 23.24
Mkt cap
$3.7B
Revenue
$54M
Q3 FY25
Revenue
$42M
FY24
RVMD
Revolution Medicines, Inc.
Change
194.28
▲
+3.25%
· post 194.00
Closed
Nov 3 '26
Mkt cap
$41.6B
Revenue
$742,000
Q4 FY23
Revenue
—
vs
Compare
Closed
Nov 3 '26
TNGX
Tango Therapeutics, Inc.
vs
RVMD
Revolution Medicines, Inc.
23.24
▲
+6.79%
post 23.24
Price
194.28
▲
+3.25%
post 194.00
$3.7B
Mkt cap
$41.6B
Q3 FY25
$54M
Revenue
$742,000
Q4 FY23
FY24
$42M
Revenue
—
Change
Change
TNGX
23.24
▲
+6.79%
vs
RVMD
194.28
▲
+3.25%
Closed
Nov 3 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
RVMD: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TNGX
1
—
WuXi AppTec
unlisted
supplier
Shared
0
No shared counterparties.
Only RVMD
6
SNY
Sanofi
customer
RPRX
Royalty Pharma Investments 2019 ICAV (Royalty Pharma)
customer
—
Aethon Therapeutics
unlisted
supplier
—
Continental Stock Transfer & Trust
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
supplier
2 more · RVMD chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TNGX, solid
RVMD, dashed